Income Tax Expense (Benefit) of Climb Bio, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Climb Bio, Inc. annual and quarterly Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Climb Bio, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was $0.
  • Climb Bio, Inc. annual Income Tax Expense (Benefit) for 2025 was $0.
  • Climb Bio, Inc. annual Income Tax Expense (Benefit) for 2024 was $0.
  • Climb Bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.
Source SEC data
View on sec.gov
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), Quarterly (USD)

Climb Bio, Inc. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $0 $0 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 $0 $0 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 $0 $0 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $0 $0 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
2020 $0 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2022 2021 FY

Climb Bio, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 $0 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q3 2024 $0 $0 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q3 2023 $0 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q1 2023 $0 $0 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.